The new progress in cancer immunotherapy Ajmeri Sultana ShimuHua-xing WeiBofeng Li Review Article Open access 15 September 2022 Pages: 553 - 567
Immunotherapy for hepatocellular carcinoma Mingzhen ZhouBaorui LiuJie Shen Review Article 24 August 2022 Pages: 569 - 577
Anti-PD-1/PD-L1 immunotherapy in conversion treatment of locally advanced hepatocellular carcinoma Jiaqi ChenDing ZhangYing Yuan Review Article 26 August 2022 Pages: 579 - 590
The immunomodulatory role of all-trans retinoic acid in tumor microenvironment Guoshu BiJiaqi LiangCheng Zhan Review Article 13 July 2022 Pages: 591 - 606
Intraabdominal sporadic desmoid tumors and inflammation: an updated literature review and presentation and insights on pathogenesis of synchronous sporadic mesenteric desmoid tumors occurring after surgery for necrotizing pancreatitis Francesco PreteMariaTeresa RotelliAngela Gurrado Review Article Open access 01 August 2022 Pages: 607 - 617
Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies Alla KuznetsovaOlga PopovaAlexey Ivanov Review Article 09 September 2022 Pages: 619 - 643
Pathophysiology of deep vein thrombosis Simón NavarreteCarla SolarIván Palomo Review Article 26 April 2022 Pages: 645 - 654
Coagulopathy during COVID-19 infection: a brief review Robin M. CunninghamKyle L. Johnson MooreJacen S. Moore Review Article 19 September 2022 Pages: 655 - 666
Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome Maria Angela BarlettaGerardo MarinoPietro Gatti Review Article 22 August 2022 Pages: 667 - 678
Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties Hayder M. Al-kuraishyAli I. Al-GareebGaber El-Saber Batiha Review Article 24 May 2022 Pages: 679 - 688
Significant association between HIV infection and increased risk of COVID-19 mortality: a meta-analysis based on adjusted effect estimates Xueya HanHongjie HouYadong Wang Review Article 13 June 2022 Pages: 689 - 700
Reactivation rates of hepatitis B or C or HIV in patients with psoriasis using biological therapies: a systematic review and meta-analysis Lin LiXian JiangYanyan Feng Review Article 30 April 2022 Pages: 701 - 715
Novel targeted C3 inhibitor pegcetacoplan for paroxysmal nocturnal hemoglobinuria Bo Xu Review Article 19 April 2022 Pages: 717 - 726
Practical therapy for primary autoimmune hemolytic anemia in adults Maria Celeste FatoneLorenzo Cirasino Review Article 18 August 2022 Pages: 727 - 736
MiR-1290: a potential therapeutic target for regenerative medicine or diagnosis and treatment of non-malignant diseases Mohammad Reza KalhoriMasoud SoleimaniAmir Ali Kalhori Review Article 08 July 2022 Pages: 737 - 750
A systematic review and meta-analysis of homocysteine concentrations in chronic obstructive pulmonary disease Angelo ZinelluElisabetta ZinelluPietro Pirina Review Article Open access 05 May 2022 Pages: 751 - 758
Kidney function and renal resistive index in children with juvenile idiopathic arthritis Alessandro CafarottiMaria Loredana MarcovecchioLuciana Breda Review Article Open access 21 September 2022 Pages: 759 - 766
Plasma lipidome acts as diagnostic marker and predictor for cyclosporin response in patients with aplastic anemia Jing RuanChen YangBing Han Original Article 21 April 2022 Pages: 767 - 776
ARID1A has prognostic value in acute myeloid leukemia and promotes cell proliferation via TGF-β1/SMAD3 signaling Tianying RenJing WangDawei Yang Original Article 22 July 2022 Pages: 777 - 785
Immunophenotypic changes of monocytes in myelodysplastic syndrome and clinical significance Lijuan LiShunjie YuRong Fu Original Article 02 August 2022 Pages: 787 - 801
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases Vincent JachietLaure RicardMINHEMON: French Network of dysimmune disorders associated with hemopathies Original Article 11 August 2022 Pages: 803 - 813
Clinical significance of circulating neutrophils and lymphocyte subsets in newly diagnosed patients with diffuse large B-cell lymphoma Zhiluo YangWei Yu Original Article 08 August 2022 Pages: 815 - 822
Correction to: Clinical significance of circulating neutrophils and lymphocyte subsets in newly diagnosed patients with diffuse large B‑cell lymphoma Zhiluo YangWei Yu Correction 13 September 2022 Pages: 823 - 823
Effect of Lugol’s solution on 131I therapy efficacy in Graves’ disease Jinyan ChaiRuiguo ZhangRenfei Wang Original Article 15 July 2022 Pages: 825 - 831
Papillary thyroid cancer with Hashimoto’s thyroiditis attenuates the tumour aggressiveness through the up-regulation of E-cadherin and TGF-β expression Su Jin KimSeung-Eun LeeEun Sook Kim Original Article Open access 24 July 2022 Pages: 833 - 840
LncRNA H19 is a potential biomarker and correlated with immune infiltration in thyroid carcinoma Yunus Sahin Original Article 09 July 2022 Pages: 841 - 851
Beta-adrenergic receptor blockers and hepatocellular carcinoma survival: a systemic review and meta-analysis Hyun ChangSung Hyun Lee Original Article 23 June 2022 Pages: 853 - 858
Immunohistochemical expression of PD-L1 and MDR1 in breast tumors: association with clinico-pathological parameters and treatment outcome Gisha Rose AntonyPaul AugustineLakshmi Subhadradevi Original Article 09 July 2022 Pages: 859 - 869
Ras suppressor-1 (RSU1) exerts a tumor suppressive role with prognostic significance in lung adenocarcinoma Sofia NikouMarina ArbiVasiliki Bravou Original Article 21 June 2022 Pages: 871 - 885
The interaction of hsa_circ_0002594 and eIF4A3 promotes T-helper 2 cell differentiation by the regulation of PTEN Jian WangYuping Cheng Original Article 23 July 2022 Pages: 887 - 895
Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement Francesco IannazzoChiara PellicanoEdoardo Rosato Original Article Open access 25 July 2022 Pages: 897 - 903
Effect of vasodilator and immunosuppressive therapy on the endothelial dysfunction in patients with systemic sclerosis Dipanjan BhattacharjeeSumantro MondalAlakendu Ghosh Original Article 25 June 2022 Pages: 905 - 915
Anti-staphylococcal responses and their relationship with HLA-DR-DQ polymorphism in granulomatosis with polyangiitis: a preliminary evidence of association with disease outcome Lekha RaniJagdeep SinghRanjana W. Minz Original Article 26 July 2022 Pages: 917 - 927
Gender dimorphism in IgA subclasses in T2-high asthma Gilda VarricchiRemo PotoGiuseppe Spadaro Original Article Open access 25 April 2022 Pages: 929 - 941
Association of triglyceride–glucose index and the presence of low muscle mass in type 2 diabetes patients Wenchao HuYingqiang MaDongming Xing Original Article 23 May 2022 Pages: 943 - 949
Autoimmunity in sarcoidosis: the tip of the Iceberg Konstantinos I. PapadopoulosBengt Hallengren Letter to the Editor 17 August 2022 Pages: 951 - 953
Comment on “immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab” Rujittika MungmunpuntipantipViroj Wiwanitkit Letter to the Editor 02 September 2022 Pages: 955 - 955